Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)
Public ClinicalTrials.gov record NCT02396238. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR): A Randomized, Double-Blind, Placebo-Controlled Trial With Incomplete Crossover
Study identification
- NCT ID
- NCT02396238
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Cytori Therapeutics
- Industry
- Enrollment
- 88 participants
Conditions and interventions
Interventions
- Celution Device Device
- Placebo Other
Device · Other
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 14, 2015
- Primary completion
- Sep 18, 2017
- Completion
- May 21, 2018
- Last update posted
- Jun 3, 2018
2015 – 2018
United States locations
- U.S. sites
- 19
- U.S. states
- 17
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Arthritis and Rheumatology Research, PLLC | Phoenix | Arizona | 85253 | — |
| Baptist Health Center for Clinical Research | Little Rock | Arkansas | 72205 | — |
| Arthritis Associates of Southern California | Los Angeles | California | 90045 | — |
| UCLA David Geffen School of Medicine | Los Angeles | California | 90095 | — |
| Georgetown University Hospital | Washington D.C. | District of Columbia | 20007 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Heartland Research Associates | Wichita | Kansas | 67207 | — |
| Central Kentucky Research Associates, Inc. | Lexington | Kentucky | 40509 | — |
| Johns Hopkins University | Baltimore | Maryland | 21224 | — |
| Boston University Medical Center | Boston | Massachusetts | 02118 | — |
| West Michigan Rheumatology, PLLC | Grand Rapids | Michigan | 49546 | — |
| Center For Pharmaceutical Research | Kansas City | Missouri | 64114 | — |
| Robert Wood Johnson Medical School | New Brunswick | New Jersey | 08901 | — |
| Hospital for Special Surgery | New York | New York | 10021 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15261 | — |
| University of Texas Houston Medical School | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02396238, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 3, 2018 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02396238 live on ClinicalTrials.gov.